-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Parkinson's disease (PD) is the second most common neurodegenerative disease; it is characterized by progressive death of dopaminergic neurons and accumulation of Lewy bodies, particularly alpha-synuclein
.
Recent evidence suggests that neuroinflammation plays an important role in Parkinson's disease
Parkinson's disease (PD) is the second most common neurodegenerative disease; it is characterized by progressive death of dopaminergic neurons and accumulation of Lewy bodies, particularly alpha-synuclein
In particular, previous studies have linked PD to autoimmune disease, microglial activation, histopathology of peripheral immune cell infiltration in the brain, and immune cell and cytokine dysregulation in peripheral blood
.
An abnormal immune system increases susceptibility to PD;In particular, previous studies have linked PD to autoimmune disease, microglial activation, histopathology of peripheral immune cell infiltration in the brain, and immune cell and cytokine dysregulation in peripheral blood
Therefore, identifying pathogenic immune targets is crucial to provide a new direction for exploring the pathogenesis of PD
Notably, α-syapsin-reactive T cells could be detected even 10 years before PD diagnosis ; this supports a role for immune inflammation in PD pathogenesis
In particular, one study found high levels of interleukin-4 (IL-4), IL-6, and IL-10 expression in PD patients; of these, IL-6 was associated with an increased risk of death
In this way, Jun Tian et al.
from the Second Affiliated Hospital of Zhejiang University explored the specific immune cell subtypes in the peripheral blood of PD patients of different onset ages
They included 22 patients; 10 with early-onset PD (EOPD), 12 with late-onset PD (LOPD), 10 young healthy controls (YHCs) and 8 elderly HCs (EHCs)
Accurate immunophenotyping of cell populations in peripheral blood was performed using mass spectrometry staining
T-test and ANOVA statistical analysis were performed on the frequencies of annotated cell populations
.
Linear regression models were used to analyze the correlation between cell populations and clinical symptoms
T-test and ANOVA statistical analysis were performed on the frequencies of annotated cell populations
They characterized 60 cell populations and found that the immune signature of PD consists of changes in cell populations, including a decrease in effector CD8+ T cells, a decrease in cytotoxic natural killer (NK) cells, and an increase in activated monocytes in PD patients
CD8+ T cells, NK cells, and monocytes are all associated with PD
.
In addition, there may be some differences in the immune status of EOPD and LOPD patients, suggesting that the pathogenesis of these two groups of patients is different
.
.
Original source:
Original source:
Tian J, Dai SB, Jiang SS, et al.
Specific immune status in Parkinson's disease at different ages of onset.
npj Parkinsons Dis.
2022;8(1):5.
doi:10.
1038/s41531-021-00271-x
Tian J, Dai SB, Jiang SS, et al.
Specific immune status in Parkinson's disease at different ages of onset.
npj Parkinsons Dis.
2022;8(1):5.
doi:10.
1038/s41531-021-00271-x here message